The meaning of our business is to make your success, to help you meet your challenges, day after day, year after year. Because beautiful stories are always written together.
The unification of the three previous laboratories aims to increase efficiency and shorten project deadlines by speeding up the interaction between the different functions and applications of minerals in various industries.
Representing only 0.1% of global cement usage, calcium aluminate specialty binders are true enablers in the world of construction, allowing builders to save time, boost productivity and leverage many innovations and sustainable options.
The future of construction is sustainable. That future is what Imerys scientists recently exhibited at the Calcined Clays for Sustainable Concrete event in Lausanne, Switzerland with their white paper on low CO2 binder acceleration technology.
Strengthening relations and creating talent pools: Imerys signs partnership with the BUCT Beijing university
As Imerys grows in China and Asia, so too does its presence and reputation as a leading employer in the region. The recently signed academic-industrial partnership with Beijing University of Chemical Technology (BUCT) – Paris Curie Engineer School opens the doors to international careers for young talent with valuable local insight and skills.
Imerys exhibited and presented at this week’s UNITECR, a key technical conference for the refractory industry. Experts from the Group discussed new products, sustainability and how to support young professionals in the industry.
As it seeks to take on the challenges and opportunities of the future, Imerys needs partners in innovation with whom it can fully leverage the latest emerging and transformative research.
Calcium aluminate has been used in sewer environments since the 1940s. Initially, the drivers for its use included its resistance to sulfates in soil, rapid return to service and superior abrasion resistance.
The team's joint efforts brought recognition from the Center for Disease Control and Prevention (CDC).